PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
IntroductionImmune checkpoint inhibitors (ICI) have revolutionized the treatment of many malignancies in recent years. However, immune−related adverse events (irAE) are a frequent concern in clinical practice. The safety profile of ICI for the treatment of malignancies in patients diagnosed with aut...
Main Authors: | Lorenz Kocheise, Ignazio Piseddu, Joscha Vonderlin, Eric T. Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jérôme Dumortier, Mar Riveiro Barciela, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londoño, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Jan P. Sutter, Thorben W. Fründt, Ansgar W. Lohse, Samuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2023.1326078/full |
Similar Items
-
Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
by: Lorenz Kocheise, et al.
Published: (2024-01-01) -
HLA, gut microbiome and hepatic autoimmunity
by: Benedetta Terziroli Beretta-Piccoli, et al.
Published: (2022-08-01) -
Accuracy of controlled attenuation parameter measurement for the detection of steatosis in autoimmune liver diseases
by: Silja Steinmann, et al.
Published: (2023-12-01) -
Preparing an Effective School Trip: Precision Work
by: Raffaele Beretta Piccoli
Published: (2023-12-01) -
La scuola e la verità
by: Raffaele Beretta Piccoli
Published: (2023-06-01)